Adaptation of Research Infrastructure to Meet the Priorities of Global Public Health.
作者信息
Moritz Rebecca L, Gillum David R
机构信息
Colorado State University, Biosafety Office, Fort Collins, CO, United States.
Environmental Health and Safety, Arizona State University, Tempe, AZ, United States.
出版信息
Front Bioeng Biotechnol. 2021 Jan 7;8:613253. doi: 10.3389/fbioe.2020.613253. eCollection 2020.
Abstract
摘要
相似文献
1
Adaptation of Research Infrastructure to Meet the Priorities of Global Public Health.调整研究基础设施以满足全球公共卫生的优先事项。
Front Bioeng Biotechnol. 2021 Jan 7;8:613253. doi: 10.3389/fbioe.2020.613253. eCollection 2020.
2
Analysis of Inactivation of SARS-CoV-2 by Specimen Transport Media, Nucleic Acid Extraction Reagents, Detergents, and Fixatives.分析标本运输介质、核酸提取试剂、清洁剂和固定剂对 SARS-CoV-2 的灭活作用。
J Clin Microbiol. 2020 Oct 21;58(11). doi: 10.1128/JCM.01713-20.
3
Procedures for Flow Cytometry-Based Sorting of Unfixed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Cells and Other Infectious Agents.基于流式细胞术的未固定严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）感染细胞和其他传染性病原体的分选程序。
Cytometry A. 2020 Jul;97(7):674-680. doi: 10.1002/cyto.a.24040. Epub 2020 Jun 3.
4
Canadian Public Health Laboratory Network Best Practices for COVID-19.加拿大公共卫生实验室网络新冠病毒病最佳实践
Can Commun Dis Rep. 2020 May 7;46(5):112-118. doi: 10.14745/ccdr.v46i05a02.
5
Laboratory Biosafety Considerations of SARS-CoV-2 at Biosafety Level 2.实验室生物安全考虑 SARS-CoV-2 在生物安全级别 2 下的情况。
Health Secur. 2020 May/Jun;18(3):232-236. doi: 10.1089/hs.2020.0021. Epub 2020 Jun 9.
6
[Prevention and control of SARS-CoV-2 infection in clinical laboratories: implementation of contingency plan and postpandemic response strategies].[临床实验室中严重急性呼吸综合征冠状病毒2感染的预防与控制：应急预案的实施及大流行后应对策略]
Nan Fang Yi Ke Da Xue Xue Bao. 2020 Apr 30;40(4):606-608. doi: 10.12122/j.issn.1673-4254.2020.04.25.
7
Biosafety measures for preventing infection from COVID-19 in clinical laboratories: IFCC Taskforce Recommendations.临床实验室预防 COVID-19 感染的生物安全措施：IFCC 工作组建议。
Clin Chem Lab Med. 2020 Jun 25;58(7):1053-1062. doi: 10.1515/cclm-2020-0633.
8
Harmonization of Biosafety and Biosecurity Standards for High-Containment Facilities in Low- and Middle-Income Countries: An Approach From the Perspective of Occupational Safety and Health.低收入和中等收入国家高防护实验室生物安全与生物安保标准的协调统一：职业安全与健康视角下的一种方法
Front Public Health. 2019 Sep 12;7:249. doi: 10.3389/fpubh.2019.00249. eCollection 2019.
9
Two Pandemics, One Challenge-Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding.两种大流行，一个挑战——利用结核病实验室的分子检测能力快速发现 COVID-19 病例。
Emerg Infect Dis. 2020 Nov;26(11):2549-2554. doi: 10.3201/eid2611.202602. Epub 2020 Sep 21.
10
Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: an IFCC global survey.《COVID-19 疫情期间生物化学实验室的运行考虑因素和挑战：IFCC 全球调查》。
Clin Chem Lab Med. 2020 Jun 4;58(9):1441-1449. doi: 10.1515/cclm-2020-0710. Print 2020 Aug 27.
引用本文的文献
1
Editorial: Diagnosis of zoonoses: Relevance of BSL3 and BSL4 facilities.社论：人畜共患病的诊断：生物安全3级和4级设施的相关性。
Front Cell Infect Microbiol. 2022 Oct 17;12:1052082. doi: 10.3389/fcimb.2022.1052082. eCollection 2022.
2
Biosafety Capacity Building During the COVID-19 Pandemic: Results, Insights, and Lessons Learned from an Online Approach in the Philippines.新冠疫情期间的生物安全能力建设：菲律宾线上模式的成果、见解与经验教训
Appl Biosaf. 2022 Mar 1;27(1):42-50. doi: 10.1089/apb.2021.0021. Epub 2022 Mar 15.
Zotero 插件